Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx3-2
|
ENSMUSG00000049691.7 | NK3 homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_41763761_41764500 | Nkx3-2 | 371 | 0.895424 | 0.42 | 1.3e-03 | Click! |
chr5_41763523_41763736 | Nkx3-2 | 872 | 0.665358 | 0.36 | 6.2e-03 | Click! |
chr5_41764546_41764740 | Nkx3-2 | 142 | 0.969037 | 0.30 | 2.4e-02 | Click! |
chr5_41768689_41768840 | Nkx3-2 | 4263 | 0.266193 | 0.27 | 5.0e-02 | Click! |
chr5_41768510_41768687 | Nkx3-2 | 4097 | 0.269548 | 0.23 | 9.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_13654565_13655321 | 16.61 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr12_3236518_3237725 | 12.71 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr18_20616739_20617639 | 10.24 |
Gm16090 |
predicted gene 16090 |
48071 |
0.1 |
chr8_103203783_103204084 | 10.14 |
Gm45391 |
predicted gene 45391 |
58987 |
0.14 |
chr6_91389110_91389432 | 9.90 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
22092 |
0.11 |
chr18_20621651_20622570 | 9.79 |
Gm16090 |
predicted gene 16090 |
43150 |
0.11 |
chr10_95075096_95075564 | 8.64 |
Gm48868 |
predicted gene, 48868 |
41049 |
0.13 |
chr18_20625060_20625736 | 8.23 |
Gm16090 |
predicted gene 16090 |
39862 |
0.12 |
chr5_28785622_28785773 | 8.18 |
Gm43161 |
predicted gene 43161 |
208424 |
0.02 |
chr1_85588537_85589247 | 8.15 |
Sp110 |
Sp110 nuclear body protein |
299 |
0.81 |
chr2_61201513_61201664 | 7.84 |
Gm13581 |
predicted gene 13581 |
23204 |
0.24 |
chr18_20615543_20616002 | 7.80 |
Gm16090 |
predicted gene 16090 |
49488 |
0.1 |
chr1_85279771_85280739 | 7.70 |
Gm16026 |
predicted pseudogene 16026 |
5148 |
0.14 |
chr4_3082761_3083956 | 7.60 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
21234 |
0.18 |
chr19_24049400_24049660 | 7.42 |
1700021P04Rik |
RIKEN cDNA 1700021P04 gene |
15263 |
0.16 |
chr4_57601641_57601807 | 7.18 |
Pakap |
paralemmin A kinase anchor protein |
33394 |
0.21 |
chr10_81364518_81366962 | 7.05 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr7_89773366_89773742 | 7.02 |
Gm15744 |
predicted gene 15744 |
11879 |
0.19 |
chr17_13590938_13591623 | 7.00 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr5_85571496_85571691 | 6.75 |
Gm43567 |
predicted gene 43567 |
149181 |
0.05 |
chr9_104443341_104443531 | 6.57 |
Mir2136 |
microRNA 2136 |
17323 |
0.19 |
chr4_143301164_143301315 | 6.44 |
Pdpn |
podoplanin |
1675 |
0.32 |
chr16_62686085_62686411 | 6.37 |
Gm9816 |
predicted pseudogene 9816 |
30789 |
0.18 |
chr4_141312456_141313176 | 6.26 |
Epha2 |
Eph receptor A2 |
3922 |
0.13 |
chr8_88604116_88604818 | 6.23 |
Nkd1 |
naked cuticle 1 |
21662 |
0.15 |
chr4_86314574_86314767 | 6.10 |
Adamtsl1 |
ADAMTS-like 1 |
37904 |
0.2 |
chr5_54158308_54158653 | 6.03 |
Stim2 |
stromal interaction molecule 2 |
42623 |
0.18 |
chr9_37359459_37360109 | 6.01 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chr4_3067329_3068553 | 5.93 |
Gm27878 |
predicted gene, 27878 |
16122 |
0.2 |
chr2_33966785_33966946 | 5.90 |
Gm13404 |
predicted gene 13404 |
11381 |
0.21 |
chr2_94273064_94274137 | 5.86 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr7_30291145_30292058 | 5.83 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
127 |
0.89 |
chr9_41446382_41446785 | 5.77 |
Gm48739 |
predicted gene, 48739 |
27532 |
0.12 |
chr10_45181043_45181210 | 5.71 |
Popdc3 |
popeye domain containing 3 |
3028 |
0.27 |
chr13_14088703_14089136 | 5.65 |
Gm26129 |
predicted gene, 26129 |
1480 |
0.31 |
chr6_51076731_51077273 | 5.63 |
Gm44402 |
predicted gene, 44402 |
109734 |
0.06 |
chr1_73992293_73993185 | 5.61 |
Tns1 |
tensin 1 |
2633 |
0.33 |
chr7_75868535_75868959 | 5.53 |
Klhl25 |
kelch-like 25 |
20306 |
0.21 |
chr16_3238621_3239720 | 5.53 |
Gm23215 |
predicted gene, 23215 |
10414 |
0.18 |
chr2_7088947_7089488 | 5.49 |
Celf2 |
CUGBP, Elav-like family member 2 |
7904 |
0.3 |
chr11_4308611_4309015 | 5.47 |
Gm24803 |
predicted gene, 24803 |
15442 |
0.12 |
chr3_22006282_22006433 | 5.45 |
Gm43674 |
predicted gene 43674 |
7889 |
0.2 |
chr15_6934781_6934981 | 5.45 |
Osmr |
oncostatin M receptor |
59912 |
0.13 |
chr14_98072601_98073651 | 5.43 |
Gm16331 |
predicted gene 16331 |
45383 |
0.18 |
chr8_16033306_16033498 | 5.36 |
Csmd1 |
CUB and Sushi multiple domains 1 |
48590 |
0.18 |
chr5_66979955_66980140 | 5.35 |
Limch1 |
LIM and calponin homology domains 1 |
3029 |
0.17 |
chr17_66546834_66546985 | 5.29 |
Gm49938 |
predicted gene, 49938 |
14806 |
0.16 |
chr4_99574046_99574523 | 5.28 |
Gm12690 |
predicted gene 12690 |
4784 |
0.18 |
chr1_169704523_169704674 | 5.18 |
Rgs4 |
regulator of G-protein signaling 4 |
43025 |
0.14 |
chr7_142459385_142459826 | 5.18 |
Lsp1 |
lymphocyte specific 1 |
1204 |
0.3 |
chr7_112289469_112289834 | 5.13 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18352 |
0.26 |
chr1_75749791_75749942 | 5.13 |
Gm5257 |
predicted gene 5257 |
113476 |
0.05 |
chr8_120518680_120519145 | 5.12 |
Gm26971 |
predicted gene, 26971 |
1703 |
0.26 |
chr6_101275882_101276171 | 5.11 |
9530086O07Rik |
RIKEN cDNA 9530086O07 gene |
12484 |
0.18 |
chr10_81464661_81465630 | 5.09 |
Gm16105 |
predicted gene 16105 |
3986 |
0.08 |
chr4_31744553_31744759 | 5.03 |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
219441 |
0.02 |
chr14_84446496_84447465 | 5.02 |
Pcdh17 |
protocadherin 17 |
1527 |
0.47 |
chr12_108371321_108371691 | 5.00 |
Eml1 |
echinoderm microtubule associated protein like 1 |
549 |
0.75 |
chr6_114968557_114970098 | 4.96 |
Vgll4 |
vestigial like family member 4 |
147 |
0.97 |
chr7_34570196_34571084 | 4.96 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr8_45614756_45614915 | 4.94 |
Gm16351 |
predicted gene 16351 |
9695 |
0.17 |
chr2_33753581_33754617 | 4.93 |
Mvb12b |
multivesicular body subunit 12B |
34660 |
0.14 |
chr7_130977605_130978173 | 4.90 |
Htra1 |
HtrA serine peptidase 1 |
3781 |
0.24 |
chr3_57637746_57637919 | 4.87 |
Gm43437 |
predicted gene 43437 |
3005 |
0.15 |
chr14_99176619_99176912 | 4.86 |
Pibf1 |
progesterone immunomodulatory binding factor 1 |
194 |
0.95 |
chr2_17510016_17510384 | 4.86 |
Nebl |
nebulette |
18124 |
0.22 |
chr13_51279821_51280013 | 4.84 |
Gm6056 |
predicted gene 6056 |
59004 |
0.09 |
chr2_35592790_35592977 | 4.83 |
Dab2ip |
disabled 2 interacting protein |
10043 |
0.19 |
chr4_114416387_114416564 | 4.82 |
Trabd2b |
TraB domain containing 2B |
9751 |
0.3 |
chr4_87472854_87473077 | 4.82 |
Gm23154 |
predicted gene, 23154 |
40693 |
0.2 |
chr3_107416658_107416809 | 4.82 |
Kcnc4 |
potassium voltage gated channel, Shaw-related subfamily, member 4 |
42819 |
0.12 |
chr2_139682780_139682950 | 4.78 |
Ism1 |
isthmin 1, angiogenesis inhibitor |
4687 |
0.25 |
chr8_36679863_36680205 | 4.78 |
Dlc1 |
deleted in liver cancer 1 |
53020 |
0.16 |
chr1_184498995_184499154 | 4.76 |
2900092O11Rik |
RIKEN cDNA 2900092O11 gene |
56094 |
0.11 |
chr17_35836572_35837313 | 4.75 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr13_43733204_43733376 | 4.73 |
Gm20751 |
predicted gene, 20751 |
16499 |
0.18 |
chr14_30824678_30824829 | 4.71 |
Stimate |
STIM activating enhancer |
837 |
0.51 |
chr1_193309940_193310091 | 4.71 |
Lamb3 |
laminin, beta 3 |
7772 |
0.12 |
chr12_28120180_28120346 | 4.69 |
Gm25923 |
predicted gene, 25923 |
59735 |
0.14 |
chr1_87011737_87012058 | 4.69 |
Gm37017 |
predicted gene, 37017 |
23627 |
0.1 |
chr12_31222865_31223209 | 4.69 |
Gm48117 |
predicted gene, 48117 |
11535 |
0.12 |
chr5_13470497_13470849 | 4.68 |
Gm43130 |
predicted gene 43130 |
10355 |
0.22 |
chr2_173658978_173659962 | 4.68 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr13_31599776_31599927 | 4.68 |
1700018A04Rik |
RIKEN cDNA 1700018A04 gene |
17338 |
0.11 |
chr16_18050226_18050377 | 4.67 |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
2559 |
0.2 |
chr15_85708879_85709635 | 4.64 |
Mirlet7b |
microRNA let7b |
1938 |
0.23 |
chr1_172341011_172341571 | 4.62 |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
81 |
0.95 |
chr8_12730860_12731168 | 4.59 |
Gm15348 |
predicted gene 15348 |
11887 |
0.15 |
chr10_23063804_23063963 | 4.53 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
51313 |
0.15 |
chr1_66157265_66157416 | 4.52 |
Map2 |
microtubule-associated protein 2 |
17933 |
0.23 |
chr3_19406344_19406802 | 4.51 |
Pde7a |
phosphodiesterase 7A |
95251 |
0.07 |
chr13_45537226_45537503 | 4.51 |
Gmpr |
guanosine monophosphate reductase |
1445 |
0.5 |
chr2_105674521_105675719 | 4.49 |
Pax6 |
paired box 6 |
11 |
0.97 |
chrX_19904398_19904579 | 4.48 |
Gm5384 |
predicted gene 5384 |
10831 |
0.23 |
chr11_4063122_4063273 | 4.48 |
Sec14l3 |
SEC14-like lipid binding 3 |
1644 |
0.23 |
chr2_34015134_34015285 | 4.46 |
Gm13404 |
predicted gene 13404 |
36963 |
0.17 |
chr8_9419533_9419690 | 4.45 |
4930435N07Rik |
RIKEN cDNA 4930435N07 gene |
39481 |
0.14 |
chr10_86836803_86837117 | 4.43 |
Gm16268 |
predicted gene 16268 |
2134 |
0.23 |
chr2_93187957_93189155 | 4.43 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
635 |
0.76 |
chr14_14350947_14351733 | 4.42 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr2_48539767_48539918 | 4.42 |
Gm13481 |
predicted gene 13481 |
82597 |
0.1 |
chr10_41934443_41935500 | 4.39 |
Sesn1 |
sestrin 1 |
36598 |
0.15 |
chr7_129672015_129672215 | 4.38 |
Gm33248 |
predicted gene, 33248 |
4690 |
0.24 |
chr3_30135172_30135476 | 4.38 |
Mecom |
MDS1 and EVI1 complex locus |
5099 |
0.24 |
chr10_68095276_68095427 | 4.34 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
41275 |
0.15 |
chr12_26366491_26366654 | 4.31 |
4930549C15Rik |
RIKEN cDNA 4930549C15 gene |
19855 |
0.16 |
chr11_105312960_105313134 | 4.31 |
Mrc2 |
mannose receptor, C type 2 |
16005 |
0.18 |
chr12_52010002_52010599 | 4.29 |
Dtd2 |
D-tyrosyl-tRNA deacylase 2 |
3799 |
0.19 |
chr1_78425763_78426361 | 4.29 |
Gm28995 |
predicted gene 28995 |
7290 |
0.18 |
chr5_5360035_5360307 | 4.28 |
Cdk14 |
cyclin-dependent kinase 14 |
20022 |
0.18 |
chrX_152198430_152198581 | 4.28 |
Iqsec2 |
IQ motif and Sec7 domain 2 |
19541 |
0.17 |
chr18_32398620_32399214 | 4.27 |
Bin1 |
bridging integrator 1 |
8717 |
0.18 |
chr18_83426304_83426622 | 4.26 |
4933401L05Rik |
RIKEN cDNA 4933401L05 gene |
2984 |
0.21 |
chr15_10721367_10721724 | 4.24 |
4930556M19Rik |
RIKEN cDNA 4930556M19 gene |
3694 |
0.24 |
chr7_89517001_89517632 | 4.24 |
Prss23 |
protease, serine 23 |
200 |
0.93 |
chr13_15550750_15551042 | 4.20 |
Gli3 |
GLI-Kruppel family member GLI3 |
86916 |
0.07 |
chr18_83388154_83388317 | 4.20 |
Gm50413 |
predicted gene, 50413 |
11386 |
0.14 |
chr9_40391750_40392345 | 4.18 |
Gramd1b |
GRAM domain containing 1B |
105 |
0.96 |
chr8_88451055_88451206 | 4.16 |
Gm45497 |
predicted gene 45497 |
60009 |
0.11 |
chr2_59401966_59402147 | 4.16 |
Gm13549 |
predicted gene 13549 |
2275 |
0.27 |
chr1_164896751_164897129 | 4.14 |
Gm32569 |
predicted gene, 32569 |
2651 |
0.22 |
chr16_87208080_87208231 | 4.14 |
Gm32865 |
predicted gene, 32865 |
79716 |
0.1 |
chr14_121624088_121624245 | 4.13 |
Dock9 |
dedicator of cytokinesis 9 |
18922 |
0.22 |
chr14_4649848_4650144 | 4.13 |
Gm3239 |
predicted gene 3239 |
14196 |
0.11 |
chr7_25907468_25907623 | 4.12 |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
9221 |
0.11 |
chr13_77892438_77892993 | 4.11 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
132187 |
0.05 |
chr7_4923006_4923708 | 4.11 |
Nat14 |
N-acetyltransferase 14 |
380 |
0.65 |
chr13_93839171_93839651 | 4.10 |
Mir5624 |
microRNA 5624 |
48634 |
0.11 |
chr12_76132652_76132833 | 4.10 |
Gm7862 |
predicted gene 7862 |
19885 |
0.16 |
chr16_55523301_55523595 | 4.08 |
Mir5118 |
microRNA 5118 |
28717 |
0.22 |
chr9_13246797_13247848 | 4.07 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr4_72384628_72385513 | 4.05 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr5_3290033_3290326 | 4.04 |
Gm36548 |
predicted gene, 36548 |
19798 |
0.17 |
chr7_27178071_27179218 | 4.03 |
Rab4b |
RAB4B, member RAS oncogene family |
166 |
0.84 |
chr6_99986618_99986769 | 4.02 |
Gm33201 |
predicted gene, 33201 |
4522 |
0.24 |
chr8_55358672_55359287 | 4.02 |
Gm20586 |
predicted gene, 20586 |
173312 |
0.03 |
chr11_56762790_56762949 | 3.99 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
248518 |
0.02 |
chr4_99459523_99459887 | 3.99 |
Gm12684 |
predicted gene 12684 |
28451 |
0.13 |
chr18_23529451_23529602 | 3.98 |
Dtna |
dystrobrevin alpha |
3233 |
0.37 |
chr10_61627244_61627395 | 3.96 |
Gm28447 |
predicted gene 28447 |
16245 |
0.12 |
chr5_26991582_26992107 | 3.96 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr9_47778650_47778807 | 3.96 |
Gm47197 |
predicted gene, 47197 |
1991 |
0.38 |
chr6_39557035_39557678 | 3.95 |
Dennd2a |
DENN/MADD domain containing 2A |
511 |
0.7 |
chr10_125961290_125962183 | 3.95 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4432 |
0.33 |
chr1_108671115_108671266 | 3.95 |
Gm28283 |
predicted gene 28283 |
58676 |
0.15 |
chr18_6282228_6282680 | 3.94 |
Kif5b |
kinesin family member 5B |
40280 |
0.12 |
chr4_5963296_5963573 | 3.94 |
Gm11797 |
predicted gene 11797 |
106440 |
0.07 |
chr19_23968301_23968459 | 3.94 |
Fam189a2 |
family with sequence similarity 189, member A2 |
8055 |
0.18 |
chr7_61982238_61982629 | 3.93 |
Mir344g |
microRNA 344g |
74 |
0.49 |
chr14_19977078_19977720 | 3.93 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
150 |
0.96 |
chr4_45824007_45824800 | 3.92 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
2520 |
0.22 |
chr5_33689860_33690118 | 3.92 |
Gm42965 |
predicted gene 42965 |
7015 |
0.11 |
chr4_143099741_143099892 | 3.92 |
6330411D24Rik |
RIKEN cDNA 6330411D24 gene |
24977 |
0.15 |
chr16_34331753_34332019 | 3.90 |
Kalrn |
kalirin, RhoGEF kinase |
29913 |
0.25 |
chr3_49870866_49871019 | 3.89 |
Gm37550 |
predicted gene, 37550 |
90055 |
0.08 |
chr9_21784668_21784824 | 3.89 |
Kank2 |
KN motif and ankyrin repeat domains 2 |
13757 |
0.1 |
chr5_142701305_142702538 | 3.88 |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
180 |
0.95 |
chr1_167969520_167969851 | 3.87 |
Gm20711 |
predicted gene 20711 |
34454 |
0.23 |
chr4_98395493_98396474 | 3.86 |
Patj |
PATJ, crumbs cell polarity complex component |
91 |
0.96 |
chr1_59134427_59134771 | 3.86 |
Mpp4 |
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
11203 |
0.11 |
chr10_128322148_128323090 | 3.86 |
Cnpy2 |
canopy FGF signaling regulator 2 |
74 |
0.92 |
chr8_8037970_8038121 | 3.85 |
Gm31401 |
predicted gene, 31401 |
28621 |
0.21 |
chr12_15811718_15812067 | 3.85 |
Trib2 |
tribbles pseudokinase 2 |
4893 |
0.17 |
chr17_44736292_44736597 | 3.85 |
Runx2 |
runt related transcription factor 2 |
204 |
0.81 |
chr19_42317678_42317968 | 3.84 |
Crtac1 |
cartilage acidic protein 1 |
29869 |
0.12 |
chr11_8424923_8425214 | 3.84 |
Gm11989 |
predicted gene 11989 |
41215 |
0.18 |
chr8_55352073_55352667 | 3.83 |
Gm20586 |
predicted gene, 20586 |
179921 |
0.03 |
chr1_118672088_118672557 | 3.81 |
Gm23497 |
predicted gene, 23497 |
9499 |
0.17 |
chr12_98536903_98537054 | 3.79 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
4916 |
0.18 |
chr13_117707480_117707660 | 3.79 |
4933413L06Rik |
RIKEN cDNA 4933413L06 gene |
12417 |
0.29 |
chr12_99671556_99672061 | 3.79 |
Gm19951 |
predicted gene, 19951 |
28715 |
0.13 |
chr2_85098686_85099212 | 3.78 |
4930443O20Rik |
RIKEN cDNA 4930443O20 gene |
12488 |
0.12 |
chr12_101766445_101766798 | 3.78 |
Tc2n |
tandem C2 domains, nuclear |
48098 |
0.12 |
chr11_101791295_101791470 | 3.78 |
Etv4 |
ets variant 4 |
6011 |
0.17 |
chr13_68932303_68932454 | 3.78 |
Gm48593 |
predicted gene, 48593 |
65641 |
0.09 |
chr4_5793593_5793964 | 3.77 |
Fam110b |
family with sequence similarity 110, member B |
4306 |
0.3 |
chr11_28833985_28834136 | 3.76 |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
19144 |
0.19 |
chr2_146624336_146624504 | 3.75 |
4933406D12Rik |
RIKEN cDNA 4933406D12 gene |
81489 |
0.1 |
chr11_102606739_102606936 | 3.74 |
Fzd2 |
frizzled class receptor 2 |
2441 |
0.15 |
chr9_41697271_41698297 | 3.74 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr11_64051128_64051549 | 3.73 |
Cox10 |
heme A:farnesyltransferase cytochrome c oxidase assembly factor 10 |
28128 |
0.16 |
chr9_23345484_23345799 | 3.73 |
Bmper |
BMP-binding endothelial regulator |
28291 |
0.27 |
chr16_18050407_18050558 | 3.72 |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
2378 |
0.21 |
chr14_79136592_79136882 | 3.72 |
Vwa8 |
von Willebrand factor A domain containing 8 |
7184 |
0.15 |
chr2_147190660_147190891 | 3.72 |
6430503K07Rik |
RIKEN cDNA 6430503K07 gene |
3351 |
0.18 |
chr19_47428045_47428776 | 3.71 |
Sh3pxd2a |
SH3 and PX domains 2A |
18051 |
0.19 |
chr7_101676155_101676306 | 3.70 |
Clpb |
ClpB caseinolytic peptidase B |
5886 |
0.2 |
chr8_23387668_23387853 | 3.69 |
Sfrp1 |
secreted frizzled-related protein 1 |
23742 |
0.21 |
chr16_21271708_21272073 | 3.68 |
Mir7680 |
microRNA 7680 |
15824 |
0.15 |
chr18_21051783_21051934 | 3.68 |
Mep1b |
meprin 1 beta |
10065 |
0.2 |
chr6_91014759_91014910 | 3.67 |
Nup210 |
nucleoporin 210 |
2595 |
0.28 |
chrX_19904603_19905052 | 3.67 |
Gm5384 |
predicted gene 5384 |
11170 |
0.23 |
chr3_80802510_80803270 | 3.67 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
55 |
0.98 |
chr16_3236385_3237472 | 3.66 |
Gm23215 |
predicted gene, 23215 |
12656 |
0.18 |
chr9_108587464_108588439 | 3.64 |
Gm49209 |
predicted gene, 49209 |
899 |
0.26 |
chr8_95688419_95688627 | 3.64 |
Ndrg4 |
N-myc downstream regulated gene 4 |
10278 |
0.1 |
chr8_55355373_55355937 | 3.64 |
Gm20586 |
predicted gene, 20586 |
176636 |
0.03 |
chr7_49298503_49298820 | 3.64 |
Nav2 |
neuron navigator 2 |
5477 |
0.26 |
chr11_97682543_97682929 | 3.63 |
Cisd3 |
CDGSH iron sulfur domain 3 |
3090 |
0.1 |
chr7_4835863_4836543 | 3.62 |
Shisa7 |
shisa family member 7 |
29 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.6 | 10.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.2 | 4.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.1 | 6.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.9 | 5.7 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.8 | 7.3 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.8 | 5.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.8 | 1.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.7 | 5.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.7 | 5.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.7 | 5.1 | GO:0021564 | vagus nerve development(GO:0021564) |
1.6 | 4.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.5 | 6.2 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.5 | 3.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.5 | 7.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.5 | 4.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.4 | 4.3 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.4 | 4.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.4 | 2.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.4 | 4.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.4 | 7.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.4 | 1.4 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.4 | 1.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.4 | 4.2 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.3 | 4.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.3 | 3.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.3 | 3.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.3 | 3.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 3.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.3 | 3.9 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.3 | 3.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.2 | 3.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.2 | 3.6 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.2 | 3.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.2 | 4.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 3.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.2 | 4.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.2 | 3.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.2 | 5.9 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
1.2 | 4.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.2 | 2.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.2 | 1.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.2 | 3.5 | GO:0033058 | directional locomotion(GO:0033058) |
1.1 | 4.6 | GO:0007412 | axon target recognition(GO:0007412) |
1.1 | 4.6 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
1.1 | 3.4 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.1 | 4.5 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.1 | 2.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.1 | 5.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.1 | 3.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 3.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.0 | 3.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.0 | 3.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.0 | 3.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
1.0 | 3.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.0 | 5.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.0 | 2.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.0 | 3.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.0 | 11.0 | GO:0071625 | vocalization behavior(GO:0071625) |
1.0 | 1.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.0 | 3.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 3.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.0 | 3.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.0 | 2.9 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.0 | 2.9 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.0 | 5.8 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.0 | 2.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.9 | 1.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.9 | 6.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 2.8 | GO:0015755 | fructose transport(GO:0015755) |
0.9 | 3.7 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 3.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.9 | 4.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.9 | 2.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.9 | 7.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.9 | 4.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 3.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.8 | 13.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.8 | 2.5 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.8 | 2.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.8 | 2.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.8 | 1.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.8 | 3.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 1.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.8 | 2.4 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 2.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.8 | 2.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 1.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.8 | 2.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.8 | 2.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.8 | 2.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.8 | 2.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 0.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.8 | 0.8 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 1.5 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.8 | 5.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.8 | 0.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.8 | 3.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.7 | 5.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 2.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.7 | 3.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 2.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.7 | 5.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 3.0 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 2.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.7 | 7.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 4.4 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.7 | 2.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.7 | 3.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 1.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.7 | 0.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.7 | 0.7 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.7 | 0.7 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.7 | 0.7 | GO:0072207 | metanephric epithelium development(GO:0072207) |
0.7 | 4.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.7 | 5.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.7 | 2.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.7 | 1.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.7 | 8.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.7 | 2.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.7 | 0.7 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.7 | 2.0 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.7 | 3.3 | GO:0035989 | tendon development(GO:0035989) |
0.7 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.7 | 0.7 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.7 | 2.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.7 | 3.3 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.6 | 1.9 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.6 | 1.9 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 2.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 4.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 3.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 1.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.6 | 1.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.6 | 1.9 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 1.9 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.6 | 6.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.6 | 1.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.6 | 1.9 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.6 | 0.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.6 | 4.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.6 | 3.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.6 | 1.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.6 | 1.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.6 | 1.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 0.6 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.6 | 0.6 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 1.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 1.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 3.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.6 | 0.6 | GO:0019230 | proprioception(GO:0019230) |
0.6 | 4.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 1.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 2.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 0.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 8.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 1.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.6 | 1.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 2.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.6 | 1.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.6 | 2.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.5 | 1.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 1.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 1.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 2.2 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.5 | 3.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 1.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.5 | 2.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 1.1 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.5 | 2.1 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 1.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 1.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.5 | 1.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 2.7 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.5 | 4.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.5 | 2.1 | GO:0043586 | tongue development(GO:0043586) |
0.5 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 1.6 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.5 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.5 | 1.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.5 | 3.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 0.5 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 3.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 0.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.5 | 1.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 1.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 1.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.5 | 2.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 2.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.5 | 1.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.5 | 2.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 5.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.5 | 2.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.5 | 2.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.5 | 2.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 0.5 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.5 | 4.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 1.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.5 | 3.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.5 | 0.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.5 | 1.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.5 | 1.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.5 | 1.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 1.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 2.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 1.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 3.8 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 0.5 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 3.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.5 | 0.9 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.5 | 0.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 3.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 0.5 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.5 | 1.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 0.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.5 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 2.3 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.4 | 1.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 3.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 1.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 0.9 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 2.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 1.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 6.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 4.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 0.4 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 0.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 1.3 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 0.4 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.4 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 2.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 1.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 0.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 34.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 1.7 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.4 | 0.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.4 | 0.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 2.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 2.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.8 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 1.2 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 2.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 1.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 0.8 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 2.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 2.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.4 | 4.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.4 | 1.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.6 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.4 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 1.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.4 | 0.8 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 1.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 0.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.4 | 0.4 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.4 | 6.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 0.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.4 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 0.8 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 1.2 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 3.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 2.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.4 | 2.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 1.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 0.8 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.4 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.4 | 1.5 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.4 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 0.8 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 2.6 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.4 | 4.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.4 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 4.4 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.4 | 0.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 0.7 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 1.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 5.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 1.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 1.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.4 | 3.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 2.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.4 | 0.7 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.4 | 1.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 0.7 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.4 | 1.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 0.7 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.4 | 0.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 0.4 | GO:0002434 | immune complex clearance(GO:0002434) |
0.4 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.4 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 0.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 3.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 2.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 1.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 1.7 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 0.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 0.7 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.3 | 1.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 1.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 0.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 1.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 1.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 1.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 0.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.3 | 1.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.3 | 1.3 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 1.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 1.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 0.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.3 | 0.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 1.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 1.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 0.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 1.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.3 | 0.3 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.3 | 0.6 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 1.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 1.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 1.5 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.3 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.9 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 0.6 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.3 | 1.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 3.8 | GO:0001964 | startle response(GO:0001964) |
0.3 | 13.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 2.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 0.6 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 0.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 4.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.8 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 0.3 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 0.3 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.3 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 0.8 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 0.3 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 1.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 1.9 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 2.8 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.3 | 0.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 0.8 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.3 | 0.5 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 1.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 2.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 1.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 1.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 0.3 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 0.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 0.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 2.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.3 | 2.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 0.5 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.3 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 0.8 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.3 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.2 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 3.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.5 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.5 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.2 | 1.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 1.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 3.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 1.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 5.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 1.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 1.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 0.4 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.9 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 0.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 0.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 0.6 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 1.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 1.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.2 | 0.2 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 1.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 1.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.4 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 1.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.8 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 1.7 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 2.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 0.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 5.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 3.6 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.9 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.6 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.4 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 2.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 3.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.2 | GO:1904023 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.2 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.7 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.3 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.2 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.2 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 2.4 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.2 | 0.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.2 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 1.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.8 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.3 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.2 | 0.7 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.8 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 0.2 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.2 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.2 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.2 | 1.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.7 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.7 | GO:0061005 | cell differentiation involved in kidney development(GO:0061005) |
0.1 | 2.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.9 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.9 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.3 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 1.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 1.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.6 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.1 | 0.1 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.8 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 1.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.5 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 2.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 1.0 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 2.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.0 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.6 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.8 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.4 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 1.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 1.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 1.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 2.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.5 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
0.1 | 2.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 2.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 1.2 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.7 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0061548 | ganglion development(GO:0061548) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.2 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 1.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 1.5 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.6 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.1 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 1.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.2 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 2.2 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.7 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 1.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.0 | GO:0043133 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.4 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.7 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.3 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.0 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.0 | GO:0048857 | neural nucleus development(GO:0048857) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 1.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0086009 | membrane repolarization(GO:0086009) |
0.0 | 0.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.2 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.0 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0051938 | L-glutamate import(GO:0051938) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.6 | 4.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.5 | 10.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.3 | 5.3 | GO:1990696 | USH2 complex(GO:1990696) |
1.3 | 11.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 3.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.2 | 3.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.1 | 4.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 4.2 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 3.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.9 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 3.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 2.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 5.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 13.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 4.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.8 | 4.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 5.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 2.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 3.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 3.5 | GO:0071547 | piP-body(GO:0071547) |
0.7 | 5.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.8 | GO:1990357 | terminal web(GO:1990357) |
0.7 | 2.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 9.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 7.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 32.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 1.2 | GO:0044393 | microspike(GO:0044393) |
0.6 | 6.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 1.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 5.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 5.7 | GO:0001527 | microfibril(GO:0001527) |
0.6 | 3.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 2.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 2.5 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 2.9 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 4.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 7.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 6.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.4 | 1.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 4.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 3.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 6.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 4.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 2.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 5.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 23.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 9.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 1.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 2.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 1.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.4 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 3.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 5.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 3.3 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 2.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 7.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 2.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 5.3 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 2.2 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 39.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 12.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 3.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 1.8 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 1.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 47.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 2.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 5.1 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 2.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 3.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 1.5 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 4.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 4.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 6.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 6.5 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 3.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 8.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 4.2 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.6 | 4.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.5 | 5.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.4 | 7.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 4.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.4 | 4.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.3 | 3.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.3 | 6.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.3 | 5.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.3 | 3.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.3 | 3.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.3 | 5.1 | GO:0097001 | ceramide binding(GO:0097001) |
1.2 | 3.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.2 | 4.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 3.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.1 | 7.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.0 | 4.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 3.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 3.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.0 | 6.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 4.8 | GO:0071253 | connexin binding(GO:0071253) |
0.9 | 3.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.9 | 4.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.9 | 5.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.9 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 5.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.8 | 7.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.8 | 5.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.8 | 0.8 | GO:0048030 | disaccharide binding(GO:0048030) |
0.8 | 3.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 3.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.8 | 2.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 2.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 2.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 3.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 1.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 5.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 3.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 1.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 2.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.6 | 1.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 3.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 5.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 6.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 4.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 3.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 1.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 3.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.6 | 6.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 2.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 2.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 7.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.6 | 2.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 6.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 1.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 2.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 16.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 3.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 5.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 2.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 3.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 2.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 5.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 2.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 15.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 2.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.5 | 6.1 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 3.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 1.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 15.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 4.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 8.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.5 | 2.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 2.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 12.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 1.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.5 | 2.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 2.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 4.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 12.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 3.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 13.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 1.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 1.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 1.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 0.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 3.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 1.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 2.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 3.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 3.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 2.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 8.1 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 6.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 1.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 2.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 1.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 1.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 0.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 2.2 | GO:0018642 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 1.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 1.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 2.4 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 5.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 2.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 3.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 1.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 8.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 3.2 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 4.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 2.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 3.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 3.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 5.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 0.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 5.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 2.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 2.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 5.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 1.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 0.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.7 | GO:0043919 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 1.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 2.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.2 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 2.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 3.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 2.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 2.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 1.8 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 20.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 4.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.9 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 3.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 3.6 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.8 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.2 | 0.6 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 4.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 2.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.2 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 1.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 1.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 17.0 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 1.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 3.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 2.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 1.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 1.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 2.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 1.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.5 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.5 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.7 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 3.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 2.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 1.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.7 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 3.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 2.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 6.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 3.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 1.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.8 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.7 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.9 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.1 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.7 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 3.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 13.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 15.6 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 2.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 2.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.4 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.9 | 10.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 28.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 1.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.9 | 1.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.8 | 2.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.7 | 13.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 2.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.6 | 27.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 5.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 12.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 3.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 4.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 5.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 6.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 47.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 4.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 1.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 5.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 4.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 2.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 4.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 5.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 3.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 6.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 5.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 3.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.0 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 4.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 16.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 3.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 24.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 12.1 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 15.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.1 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.8 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 17.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 7.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 11.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 8.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 6.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 8.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 11.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 23.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 21.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 5.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 5.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 5.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 16.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 8.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 9.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 9.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 5.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 1.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.4 | 1.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 4.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 0.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 5.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 1.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 6.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 2.6 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.3 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 1.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 16.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 7.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 2.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.7 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 3.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 7.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 4.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 2.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 2.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 2.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 1.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.5 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 3.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |